BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Generated: December 12, 2017

DrugPatentWatch Database Preview

DIGOXIN Drug Profile

« Back to Dashboard

When do Digoxin patents expire, and when can generic versions of Digoxin launch?

Digoxin is a drug marketed by West-ward Pharms Int, Abraxis Pharm, Hospira, Sandoz Inc, Wyeth Ayerst, Hikma Intl Pharms, Impax Labs, Mylan Pharms Inc, Stevens J, and Sun Pharm Inds Inc. and is included in thirteen NDAs.

The generic ingredient in DIGOXIN is digoxin. There are ten drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the digoxin profile page.
Drug patent expirations by year for DIGOXIN

Pharmacology for DIGOXIN

Ingredient-typeCardiac Glycosides
Drug ClassCardiac Glycoside

Medical Subject Heading (MeSH) Categories for DIGOXIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms IntDIGOXINdigoxinELIXIR;ORAL021648-001Aug 26, 2004RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
HospiraDIGOXIN PEDIATRICdigoxinINJECTABLE;INJECTION040092-001Apr 25, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Wyeth AyerstDIGOXINdigoxinINJECTABLE;INJECTION084386-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraDIGOXINdigoxinINJECTABLE;INJECTION040206-001Aug 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncDIGOXINdigoxinTABLET;ORAL040282-001Dec 23, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma Intl PharmsDIGOXINdigoxinTABLET;ORAL077002-002Oct 30, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncDIGOXINdigoxinTABLET;ORAL076363-001Jan 31, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Stevens JDIGOXINdigoxinTABLET;ORAL076268-001Jul 26, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Abraxis PharmDIGOXINdigoxinINJECTABLE;INJECTION083217-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraDIGOXINdigoxinINJECTABLE;INJECTION040093-001May 16, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: